Utah Medical Products (NASDAQ:UTMD – Get Free Report) and CapsoVision (NASDAQ:CV – Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, earnings, valuation and dividends.
Risk and Volatility
Utah Medical Products has a beta of 0.38, suggesting that its stock price is 62% less volatile than the S&P 500. Comparatively, CapsoVision has a beta of -2.34, suggesting that its stock price is 334% less volatile than the S&P 500.
Valuation & Earnings
This table compares Utah Medical Products and CapsoVision”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Utah Medical Products | $38.52 million | 6.08 | $11.29 million | $3.34 | 22.04 |
| CapsoVision | $13.55 million | 23.16 | -$25.32 million | ($0.47) | -13.34 |
Utah Medical Products has higher revenue and earnings than CapsoVision. CapsoVision is trading at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
69.6% of Utah Medical Products shares are owned by institutional investors. 8.0% of Utah Medical Products shares are owned by insiders. Comparatively, 2.3% of CapsoVision shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Analyst Recommendations
This is a summary of current ratings and recommmendations for Utah Medical Products and CapsoVision, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Utah Medical Products | 0 | 1 | 0 | 0 | 2.00 |
| CapsoVision | 1 | 1 | 2 | 0 | 2.25 |
CapsoVision has a consensus target price of $9.50, suggesting a potential upside of 51.52%. Given CapsoVision’s stronger consensus rating and higher possible upside, analysts clearly believe CapsoVision is more favorable than Utah Medical Products.
Profitability
This table compares Utah Medical Products and CapsoVision’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Utah Medical Products | 30.48% | 8.83% | 8.59% |
| CapsoVision | -214.74% | -177.85% | -135.07% |
Summary
Utah Medical Products beats CapsoVision on 10 of the 14 factors compared between the two stocks.
About Utah Medical Products
Utah Medical Products, Inc. develops, manufactures and markets medical devices, with a focus on disposable products used in obstetrics, gynecology and neonatal care. Its offerings include devices and accessories for fetal monitoring, labor and delivery, newborn care and related clinical procedures. Founded in 1978 and headquartered in Midvale, Utah, the company also serves other areas of healthcare, including surgery and emergency care. Its products reach customers in the United States and international markets through a combination of direct sales and distribution channels.
About CapsoVision
CapsoVision develops medical technology for capsule endoscopy, a method of examining the digestive tract using a swallowable camera. Its products are designed to help clinicians visualize the small intestine as part of diagnostic evaluation. The company’s CapsoCam Plus system uses a swallowable capsule with multiple cameras to capture panoramic images as it moves through the small intestine. Images are stored in the capsule and later retrieved for review using the company’s supporting hardware and software.
Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.
